Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2005Journal of Bone and Mineral ResearchOpen Access

Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover

View Full Paper
Ask AI
Bookmark
Share

Authors

ANArja NenonenSouth Karelia Central HospitalSCSulin ChengShanghai Jiao Tong UniversityKIKaisa K. IvaskaUniversity of Turku

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nenonen et al. (2005) studied this question.

synapsesocial.com/papers/6a950caddef62415d69e6219https://doi.org/10.1359/jbmr.050403
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Disease-Specific Expression of Tartrate-Resistant Acid Phosphatase Isoforms2003 · 37 citations
  2. 2Purification and properties of the native form of the purple acid phosphatase from bovine spleen1993 · 44 citations
  3. 3Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability1998 · 263 citations
  4. 4Serum Tartrate-resistant Acid Phosphatase 5b Is a Specific and Sensitive Marker of Bone Resorption2001 · 159 citations